Diseases

Ehlers-Danlos Syndrome

ehlers-danlos syndrome

Entity Type: Diseases
Relation Groups: 3
Relation Preview: 24

Basic Information

Grouped by core information, identifiers, and descriptions.

Current candidates are inferred from disease-target-ingredient-herb paths and do not represent a formal recommendation ranking.

Core Information

Disease Name: Ehlers-Danlos Syndrome
Standard Disease Name: ehlers-danlos syndrome
MeSH Tree: No data
ICD-10: Q79.6

Identifiers

DO ID: No data
MeSH ID: D004535
OMIM ID: No data
UMLS ID: C0013720
HPO ID: No data

Description and Extensions

Description: NCI2016_02D:An inherited connective tissue disorder characterized by loose and fragile skin and joint hypermobility.|MSH2017_2016_08_12:A heterogeneous group of autosomally inherited COLLAGEN DISEASES caused by defects in the synthesis or structure of FIBRILLAR COLLAGEN. There are numerous subtypes: classical, hypermobility, vascular, and others. Common clinical features include hyperextensible skin and joints, skin fragility and reduced wound healing capability.|MEDLINEPLUS_20151021:Ehlers-Danlos syndrome (EDS) is a group of inherited disorders that weaken <a href='https://www.nlm.nih.gov/medlineplus/connectivetissuedisorders.html'>connective tissues</a>. Connective tissues are proteins that support skin, bones, blood vessels, and other organs. EDS usually affects your skin, joints and blood vessel walls. Symptoms include <ul> <li> Loose joints </li> <li> Fragile, small blood vessels </li> <li> Abnormal scar formation and wound healing </li> <li> Soft, velvety, stretchy skin that bruises easily </li> </ul> There are several types of EDS. They can range from mild to life-threatening. About 1 in 5,000 people has EDS. There is no cure. Treatment involves managing symptoms, often with medicines and physical therapy. It also includes learning how to protect your joints and prevent injuries.|CSP2006:group of inherited disorders of the connective tissue; major manifestations include hyperextensible skin and joints, easy bruisability, friability of tissues with bleeding and poor wound healing, calcified subcutaneous spheroids, and pseudotumors.

Direct relations and traceable candidates grouped by relation type.